Assessment of Long-term Impact Post COVID-19 for Patients and Health Care Professionals of the European Hospital
NCT04525911 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 214
Last updated 2022-07-27
Summary
The purpose of the study is to Assess of Long-term impact post COVID for patients and health care professionals.The patients and medical staff will be followed for 2 years in order to provide clinical and paraclinical data not yet published in the literature.
Conditions
- Covid19
Interventions
- DIAGNOSTIC_TEST
-
Diagnostic Test: serology test for COVID-19
a serology test will be performed at M3
Sponsors & Collaborators
-
Hôpital Européen Marseille
lead OTHER
Principal Investigators
-
Hervé PEGLIASCO · Hôpital Europeen Marseille
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-08-26
- Primary Completion
- 2022-08-31
- Completion
- 2022-10-31
Countries
- France
Study Locations
More Related Trials
-
Assessment of Sexual Dysfunction Among COVID-19 Recovered Patients
NCT05148819 ·Status: UNKNOWN
-
Exposure to Hepatitis E Virus in Occitania, France
NCT06137313 ·Status: RECRUITING
-
Laboratory Profile of Hepatitis B and C in Users of a Reference Service
NCT00512941 ·Status: COMPLETED
-
SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the UZ Brussel Following COVID-19 Vaccination Using an Adenoviral Vector
NCT04939402 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in France
NCT07038863 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of the Impact of the Anti COVID-19 Vaccination Campaign Addressed to the Employees of an Italian Hospital.
NCT05774418 ·Status: COMPLETED
-
CORONA Germany- Clinical Outcome and Risk in Hospitalized COVID-19 Patients - An Epidemiological Study From Germany
NCT04659187 ·Status: UNKNOWN
-
Disease Loads and Status of Treatment
NCT05264272 ·Status: UNKNOWN
-
Quantification of Binding and Neutralizing Antibody Levels in COVID-19 Vaccinated Health Care Workers Over 1 Year
NCT04910971 ·Status: UNKNOWN
-
Risk Factors and Characteristics of COVID 19 Infection in Patients With Haematological Diseases
NCT04930731 ·Status: UNKNOWN
-
Systematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University Hospital
NCT04959643 ·Status: UNKNOWN
-
New HBV Infection Biomarkers: Clinical Characterization and Impact on Management
NCT06906016 ·Status: RECRUITING
-
Post-COVID-19 Condition: Observational Study in Vietnam
NCT06022211 ·Status: UNKNOWN
-
COVID-19 Vaccines in Patients With Chronic Liver Disease
NCT05017805 ·Status: UNKNOWN ·Phase: NA
-
A Comprehensive HBsAg-positive Patients Centered Screening Strategy
NCT03794791 ·Status: COMPLETED
-
Serological Surveillance for COVID-19 in Central North Carolina
NCT04490174 ·Status: COMPLETED
-
Corona Virus Infection Among Liver Transplant Recipients
NCT04565782 ·Status: UNKNOWN
-
National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses
NCT04166266 ·Status: RECRUITING
-
Testing and Epidemiology of Delta Hepatitis
NCT05181956 ·Status: UNKNOWN
-
Safety and Immune Response of COVID-19 Vaccination in Patients With Chronic Liver Diseases
NCT05007665 ·Status: UNKNOWN
-
Study on Gut Microbiota in Chronic HBV Infected Patients
NCT03587467 ·Status: UNKNOWN
-
Safety and Immunogenicity of COVID-19 Vaccine Booster in Patients With Liver Diseases
NCT05204602 ·Status: UNKNOWN
-
Epidemiological Study in Children and Adolescents With Chronic Hepatitis B
NCT01163240 ·Status: COMPLETED
-
Hepatitis C Surveillance With Linkage to Care of Patients From Non-ID Departments in Jiangsu
NCT03772002 ·Status: UNKNOWN ·Phase: NA
-
Seroprevalence Hepatitis E Infection in Healthy Blood Donors
NCT03601221 ·Status: COMPLETED